AI ‐ ECG for early detection of atrial fibrillation: First‐year results from a stroke prevention study in Shimizu, Japan
Rattachement africain : jp. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Abstract Background An artificial intelligence algorithm‐guided electrocardiogram (AI‐ECG) has been developed to detect atrial fibrillation (AF) in patients with sinus rhythm (SR). However, its utility for population‐based screening remains unclear in Japan. Method and Results In this prospective cohort study, “SPAFS” (Stroke Prevention by Early Detection of AF in Shimizu), participants who underwent health examinations at the Shimizu Medical Association Examination Center from January 2022 to July 2023 were enrolled, with known AF excluded. ECGs were categorized by AI as low‐, moderate‐, or high risk: non‐SR were labeled as non‐applicable (NA). All participants underwent 7‐day single‐lead ECG monitoring. Among 362 participants (61.1 ± 10.5 years, 38% male, CHADS2 score 0.49 ± 0.70), AF was newly detected in 3.0% ( n = 11), with increasing prevalence across AI risk categories. The non‐low‐risk group (moderate, high, and NA) had a significantly higher AF detection rate than the low‐risk group (OR 9.36, 95% CI 1.99–44.01). Subgroup analysis in those aged ≥65 years showed a similar trend (OR 8.09 [95%CI 1.63–39.7]). When the NA group (not eligible for AI) was excluded, similar trends were observed, although statistical significance was attenuated (OR 4.89 [95% CI 0.88–27.1] in the total, 5.09 [95% CI 0.89–29.0] in those aged ≥65 years). In the total cohort, AI‐ECG showed higher discriminative ability than the CHADS 2 score ≥1 in both the total cohort (AUC 0.75 vs. 0.68) and participants aged ≥65 years (AUC 0.73 vs. 0.61). Conclusions AI‐ECG risk determination correlated with AF detection in a Japanese healthy cohort, especially in the aged population, supporting its utility as a population‐based screening tool.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- <scp>AI</scp> ‐ <scp>ECG</scp> for early detection of atrial fibrillation: First‐year results from a stroke prevention study in Shimizu, Japan
- Date Crossref
- 04/07/2025
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
Shizuoka City Shimizu Hospital Department of Cardiology pays non établi dans la noticeÉtablissement de santé
-
Shimizu (Japan) pays non établi dans la noticeEntreprise
-
Shizuoka Medical Center pays non établi dans la noticeÉtablissement de santé
-
National Disaster Medical Center pays non établi dans la noticeÉtablissement de santé
-
Yokohama Municipal Minato Red Cross Hospital pays non établi dans la noticeÉtablissement de santé
-
Tsuchiura Kyodo General Hospital pays non établi dans la noticeÉtablissement de santé
-
Yokosuka Kyosai Hospital Department of Cardiology pays non établi dans la noticeÉtablissement de santé
-
Jichi Medical University Division of Clinical Pharmacology and Division of Cardiovascular Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Jichi Medical University Saitama Medical Center pays non établi dans la noticeÉtablissement de santé
-
Cardiovascular Institute Hospital pays non établi dans la noticeÉtablissement de santé
-
Institute of Science Tokyo Department of Cardiovascular Medicine pays non établi dans la noticeUniversité ou école supérieure
-
Tokyo Metropolitan Institute of Medical Science pays non établi dans la noticeStructure de recherche
Department of Cardiology — Shizuoka City Shimizu Hospital, Shimizu (Japan) et Shizuoka Medical Center, avec 9 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.